- Home
- MANU vs PTGX Comparison
MANU vs PTGX Comparison
Compare MANU & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- PTGX
- Stock Information
- Founded
- MANU 1878
- PTGX 2006
- Country
- MANU United Kingdom
- PTGX United States
- Employees
- MANU N/A
- PTGX N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- MANU Consumer Discretionary
- PTGX Health Care
- Exchange
- MANU Nasdaq
- PTGX Nasdaq
- Market Cap
- MANU 3.1B
- PTGX 3.3B
- IPO Year
- MANU 2012
- PTGX 2016
- Fundamental
- Price
- MANU $17.52
- PTGX $57.48
- Analyst Decision
- MANU Strong Buy
- PTGX Strong Buy
- Analyst Count
- MANU 1
- PTGX 8
- Target Price
- MANU $23.00
- PTGX $70.13
- AVG Volume (30 Days)
- MANU 160.4K
- PTGX 604.7K
- Earning Date
- MANU 09-10-2025
- PTGX 08-06-2025
- Dividend Yield
- MANU N/A
- PTGX N/A
- EPS Growth
- MANU N/A
- PTGX N/A
- EPS
- MANU N/A
- PTGX 0.80
- Revenue
- MANU $832,748,485.00
- PTGX $209,180,000.00
- Revenue This Year
- MANU $2.95
- PTGX N/A
- Revenue Next Year
- MANU $2.10
- PTGX $53.09
- P/E Ratio
- MANU N/A
- PTGX $71.30
- Revenue Growth
- MANU N/A
- PTGX N/A
- 52 Week Low
- MANU $12.05
- PTGX $33.31
- 52 Week High
- MANU $19.65
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- MANU 49.80
- PTGX 62.14
- Support Level
- MANU $17.16
- PTGX $55.26
- Resistance Level
- MANU $17.93
- PTGX $57.10
- Average True Range (ATR)
- MANU 0.37
- PTGX 2.04
- MACD
- MANU -0.06
- PTGX 0.27
- Stochastic Oscillator
- MANU 40.79
- PTGX 93.20
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.